DOCSLIB.ORG

377 a Abnormal Tooth Development Ankyloglossia , 99 Caries And

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
377 a Abnormal Tooth Development Ankyloglossia , 99 Caries And Index A dietary management , 16–17 Abnormal tooth development liver transplantation , 16 ankyloglossia , 99 Richner–Hanhart’s syndrome , 16 caries and erosion , 99–100 synthesis , 16 dentin formation , 98 treatment , 16 enamel hypoplasia , 98 tyrosinemia type II , 17 etiology , 98 Ankyloglossia , 99 food exposures , 100–101 ANSD. See Auditory neuropathy spectrum ABR. See Auditory brainstem response (ABR) disorder (ANSD) ACTH. See Adeno corticotropic hormone (ACTH) Anti epileptic drugs (AEDs) , 27 Adeno corticotropic hormone (ACTH) , 28, 33 Antioxidants (AOXs) , 224–225 Adipocytes AOXs. See Antioxidants (AOXs) adipocyte-derived proteins, endocrine functions , 324 ARG. See Arginine (ARG) differentiation , 324 Arginine (ARG) , 223 and lymphocytes , 323 Auditory brainstem response (ABR) mature , 322 abnormalities , 201 metabolic functions , 322, 323 electro-physiological measure , 193 Adipokines , 322, 328 wave I-VII response , 193, 194, 198 Adipose tissue-secreted proteins waves , 194 adiponectin , 324–325 Auditory cortex , 192 Interleukin (IL)-6 and TNF- a , 326 Auditory neuropathy spectrum disorder leptin , 325 (ANSD) , 193 resistin , 326 visfatin , 325 American Academy of Pediatrics (AAP) B recommendations , 315–316 Bacterial illness American Heart Association (AHA) recommendations , acute diarrheal , 125 315–316 campylobacter ( see Campylobacter ) Amino acid metabolism C. dif fi cile ( see Clostridium dif fi cile ) homocystinuria description , 125 clinical manifestations , 17 E. coli ( see Escherichia coli (E. coli) ) dietary management , 17–18 salmonella (see Salmonella ) methionine , 17 vibrio cholera ( see Vibrio cholera ) hyperphenylalaninemias y. enterocolitica ( see Yersinia enterocolitica ) BH4 and PAH , 15 Bacteroides fragilis dietary management , 15–16 fecal samples , 257 Phe concentrations , 15 isolation, stool , 260 PKU , 14 Basal metabolic rate (BMR) , 236, 237 MSUD , 18–19 Bayley psychomotor developmental index , 339 PPA and MMA , 19–20 Bayley scale of infant and toddler development tyrosinemia type I (BSID) , 298 clinical symptoms and pathogenesis , 16 BF. See Cessation of breastfeeding (BF) R.R. Watson et al. (eds.), Nutrition in Infancy: Volume 2, Nutrition and Health, 377 DOI 10.1007/978-1-62703-254-4, © Springer Science+Business Media New York 2013 378 Index Birth size C adult disease , 359 CAD. See Coronary artery disease (CAD) adult obesity , 363 Caloric intake early growth , 361 dietary guidelines, Americans , 312 genetic susceptibility , 360 dyslipidemia , 315 Birth weight high-risk individual approach , 312 adipocytes , 327 maintain, body weight , 315 adiponectinemia , 328 Caloric restriction and weight loss , 325 leptin , 328 Campylobacter BMR. See Basal metabolic rate (BMR) diagnosis , 126 Body composition epidemiology/incidence , 125 chronic disease , 3 manifestation , 126 CP ( see Cerebral palsy (CP)) pathogenesis , 126 description , 3 Carbohydrate metabolism DS ( see Down syndrome (DS)) galactosemia , 21–22 Body mass index (BMI) GSD , 22 assessment , 349 Cardiopulmonary bypass (CPB) , 216 centile charts , 348 Caries , 99–100 changes, age and gender , 348 Catastrophic epileptic syndromes , 27 co-morbidities , 352 Catch-up growth Crohn’s disease , 67 infants , 171 reduction , 353 C. dif fi cile . See Clostridium dif fi cile WHO standards , 350 CD infants. See Celiac disease (CD) Body weight Celiac disease (CD) fat and fat-free components , 348 clinical manifestations , 145 measurements , 83 pediatric , 145 Bowel adaptation growth and interdisciplinary prevention , 146–147 management treatment advantages, bowel dilatation , 51 adherence to diet and follow-up , 149 cost reduction, HPN , 51–52 gluten-free diet , 147–148 follow-up , 52 history , 147 intestinal rehabilitation programs , 51 lactose intolerance , 148 life-threatening complications , 51 malnutrition , 149 management , 51 micronutrient supplementation , 149 PNALD , 51 novel non-dietary , 150 risk , 51 oats , 148 STEP , 51 Central venous catheters (CVC) survival rates , 52 home parenteral nutrition, children and adults , 249 Breast feeding insertion , 236 avoidance, HIV transmission , 176 related complications , 241 cleft lip and palate , 96 Cerebral palsy (CP) complementary , 176–179 body composition dif fi culties , 99 estimation , 6 exclusive , 176 and nutritional status , 5 formula , 179–180 centripetal fat pattern , 6 HIV-related challenges , 183–184 classi fi cation , 2 libitum , 100 clinical assessment nipple , 98 BMI growth charts , 7 termination , 99 computed stature values , 7 WHO guidelines , 182–183 growth charts, height , 6 Breast milk national health and nutrition examination bi fi dobacteria and lactobacilli , 285 surveys , 8 and colostrum , 285 nutritional status and body fat , 8 contents , 285 standard of care, pediatric examination , 6 fed infants , 285 stature measurement accuracy , 6 formula-fed , 280 Tibia length growth curves , 7–8 GI motility pattern , 286 weight and height determination , 7 IgA antibodies , 146 de fi nition , 2 infant nutrition , 279 disability , 2 vs. placebo formula , 287 growth characteristics BSID. See Bayley scale of infant and toddler age-speci fi c measures , 2 development (BSID) body size , 2 Index 379 failure, malnutrition , 2 function , 255 feeding dif fi culties , 3 immune system, bacterial colonization , 257 NAGCPP , 3 intestinal, development , 256 nutritional compromise and disease severity , 3 lactic acid , 263 nutritional status and disease severity , 3 modulation , 255 seizure disorders , 3 physiological conditions , 263 standard deviations (SD) , 2 probiotics and potential health bene fi ts , 257–258 Cessation of breastfeeding (BF) , 146–147 Complications Childhood obesity. See Infant and childhood obesity CVC-related , 241 Children metabolic , 242 energy, glucose, lipid and amino acid PEG requirements , 248 late post-operative , 63–64 fl uid and electrolyte requirements , 248 operative and early post-operative , 62 gangliosides, neurological development , 110, 114 post-operative , 62–63 home parenteral nutrition psychosocial , 242 central venous access , 249 wound infection/erythema , 58, 59, 62, 63 complications , 250 Coronary artery disease (CAD) Chronic kidney disease (CKD) atherosclerosis , 306 de fi nition and stages , 165 blood TC and LDL-C increase , 306–307 forced nutrition , 171 diet ( see Diet) growth hormone (GH) , 171–172 dyslipidemia , 315 growth retardation follow up , 314 epidemiological data , 166 institutional recommendation , 307 pathogenic factors , 166, 167 lipoproteins , 306 guidelines, nutrition morbidity , 305 calcium and phosphate , 170–171 NCEP recommended levels , 306 energy , 168, 170 NHANES , 305, 306 nutritional and growth status, evaluation , 168, 169 nutritional assessment and counseling , 314 protein , 169 nutritional supplements ( see Nutritional sodium chloride , 169 supplements) vitamin and trace element , 170 prevalence , 305–306 malnutrition , 167 risk factors , 306 nutritional targets , 166–167 screening , 306 pathophysiology, cachexia/PEW , 167 therapy , 314–315 pediatric renal nutrition therapy , 166 CPB. See Cardiopulmonary bypass (CPB) renal excretion, anorexigenic peptides , 167–168 C-reactive protein (CRP) , 66 serum leptin , 168 Critical illness. See Metabolic response CKD. See Chronic kidney disease (CKD) Crohn’s disease Clinical trials, LCPUFA. See Long chain polyunsaturated abdominal pain , 66 fatty acids (LC-PUFAs) characterization , 65 Clostridium dif fi cile clinical practice diagnosis/treatment , 133 EEN ( see Exclusive enteral nutrition (EEN)) epidemiology/incidence , 132–133 food re-introduction , 71 manifestation , 133 poor weight gain , 71 pathogenesis , 133 remission maintenance , 72–73 Colonic fl ora therapeutic options , 71–72 carbohydrate fermentation treatment , 70–71 absorption, SCFA , 261–262 CRP and ESR , 66 actinomyces bacteroides , 258–259 diagnoses , 65–66 asymptomatic carrier , 262 features , 66 Bacteroides fragilis , 260 history and examination , 66 breast-fed and formula-fed infants , 260–261 in fl ammation , 66 breath H2 excretion and concentration , 260 nutrition dietary carbohydrate , 259 body composition , 67–68 fecal concentration, SCFA , 261 height , 66–67 iron supplementation , 260 micronutrients , 68 Lactobacillus species , 262 PN , 69–70 lumenal pH , 258 poor, aetiology , 66–67 malabsorption , 262 treatment, EEE and PN , 68–70 short-chain fatty acid , 258 weight and BMI , 67 fermentation , 255 symptoms , 65 380 Index CRP. See C-reactive protein (CRP) Diarrhea CVC. See Central venous catheters (CVC) diagnosis , 123 Cytokines evaluation , 122 local and systemic immune function , 214 lab testing , 123 postoperative , 217 medical evaluation , 136 proin fl ammatory , 215 parasitic infection ( see Parasitic infection) reduction , 216 pathophysiology absorption mechanisms , 120 acute infectious algorithm , 121 D etiology , 122 Dehydration , 135–136 intestinal tract , 120 Dental development oral rehydration therapy , 120 abnormal tooth ( see Abnormal tooth development) osmotic, secretory, motility, and in fl ammatory , chronology, human dentition , 95 120–121 formation, oral structures , 94 World Health Organization (WHO) , 121 intrauterine growth disturbances Diet cleft lip and palate , 96 CAD, childhood craniofacial malformations , 96 dietary intervention ( see Dietary intervention) dental eruption , 98 effects, low-fat , 312 fetal alcohol spectrum disorders , 96 hypercholesterolemia , 307 low birth weight/prematurity , 97 nutritional supplements ( see Nutritional oromotor dysfunction , 97–98 supplements) syndrome , 96 therapy
Load more

Recommended publications
  • Opinion of Trustees Resolution of Dispute Case No
    Opinion of Trustees Resolution of Dispute Case No. 88-122 Page 1 _____________________________________________________________________________ OPINION OF TRUSTEES _____________________________________________________________________________ In Re Complainant: Employee Respondent: Employer ROD Case No: 88-122 - October 3, 1989 Board of Trustees: Joseph P. Connors, Sr., Chairman; Paul R. Dean, Trustee; William Miller, Trustee; Donald E. Pierce, Jr., Trustee; Thomas H. Saggau, Trustee. Pursuant to Article IX of the United Mine Workers of America ("UMWA") 1950 Benefit Plan and Trust, and under the authority of an exemption granted by the United States Department of Labor, the Trustees have reviewed the facts and circumstances of this dispute concerning the provision of health benefits coverage for orthodontic treatment under the terms of the Employer Benefit Plan. Background Facts An oral surgeon states that the Employee's daughter began experiencing pain and popping in the right temporomandibular joint after being hit in the area of the right mandible during a fight in March 1985. She was treated by a physical therapist and had splint therapy to correct her temporomandibular joint problems for about six months. In August 1985, the Employee's daughter suffered a second injury to the right side of the head. She continued having pain and popping in the right temporomandibular joint, and surgery, an arthroplasty of the joint, was performed in December 1986. The Employer provided coverage for the physical therapy, the splint therapy and the surgery to correct her temporomandibular joint problems. In March 1988, an oral surgeon recommended orthodontic treatment to alleviate all of the Employee's daughter's symptoms. The Employee's daughter was examined by an orthodontist on May 10, 1988; he noted that she had reciprocal clicking in both temporomandibular joints, lack of proper chewing motion, limited mobility of the mandible, frequent headaches, and tenderness in the right jaw joint.
    [Show full text]
  • AN OVERVIEW of VESICOBULLOUS CONDITIONS AFFECTING the ORAL MUCOSA EMMA HAYES, STEPHEN J CHALLACOMBE Prim Dent J
    AN OVERVIEW OF VESICOBULLOUS CONDITIONS AFFECTING THE ORAL MUCOSA EMMA HAYES, STEPHEN J CHALLACOMBE Prim Dent J. 2016; 5(1):46-50 in the palate, buccal mucosa and labial ABSTRACT mucosa there is an underlying submucosa. The epithelium is formed of several layers, Vesicobullous diseases are characterised by the presence of vesicles or bullae at the deepest being the layer of progenitor varying locations in the mucosa. The most common occurring in the oral cavity cells forming the stratum germinativum, are mucous membrane pemphigoid (MMP) and pemphigus vulgaris (PV). Both adjacent to the lamina propria. are autoimmune diseases with a peak age onset of over 60 years and females Keratinocytes increase in size and flatten are more commonly affected than men. This paper reviews the structure of the as they move through the stratum spinosum oral mucosa, with specific reference to the basement membrane zone, as well and stratum granulosum to the stratum as bullous conditions affecting the mucosa, including PV and pemphigoid, their corneum (in keratinized mucosa) where the aetiology, clinical presentation, and management. desmosomes, which hold the cells together, weaken – therefore allowing normal Learning outcomes desquamation. • Understand the common presentation of vesicobullous diseases. • Appreciate the role of investigations in diagnosis and its interpretation. In addition to desmosomes, epithelial • Appreciate the roles of both primary and secondary care in patient management. cell-cell contact occurs via occludens (tight junctions), and nexus junctions (gap junctions), with each having a complex structure. Desmosomes are small adhesion Introduction proteins (0.2µm) 1 which guarantee the Vesicobullous diseases are characterised by integrity of the epidermis by linking the the presence of vesicles or bullae at varying intermediate filaments within cells to the locations in the mucosa.
    [Show full text]
  • Megaesophagus in Congenital Diaphragmatic Hernia
    Megaesophagus in congenital diaphragmatic hernia M. Prakash, Z. Ninan1, V. Avirat1, N. Madhavan1, J. S. Mohammed1 Neonatal Intensive Care Unit, and 1Department of Paediatric Surgery, Royal Hospital, Muscat, Oman For correspondence: Dr. P. Manikoth, Neonatal Intensive Care Unit, Royal Hospital, Muscat, Oman. E-mail: [email protected] ABSTRACT A newborn with megaesophagus associated with a left sided congenital diaphragmatic hernia is reported. This is an under recognized condition associated with herniation of the stomach into the chest and results in chronic morbidity with impairment of growth due to severe gastro esophageal reflux and feed intolerance. The infant was treated successfully by repair of the diaphragmatic hernia and subsequently Case Report Case Report Case Report Case Report Case Report by fundoplication. The megaesophagus associated with diaphragmatic hernia may not require surgical correction in the absence of severe symptoms. Key words: Congenital diaphragmatic hernia, megaesophagus How to cite this article: Prakash M, Ninan Z, Avirat V, Madhavan N, Mohammed JS. Megaesophagus in congenital diaphragmatic hernia. Indian J Surg 2005;67:327-9. Congenital diaphragmatic hernia (CDH) com- neonate immediately intubated and ventilated. His monly occurs through the posterolateral de- vital signs improved dramatically with positive pres- fect of Bochdalek and left sided hernias are sure ventilation and he received antibiotics, sedation, more common than right. The incidence and muscle paralysis and inotropes to stabilize his gener- variety of associated malformations are high- al condition. A plain radiograph of the chest and ab- ly variable and may be related to the side of domen revealed a left sided diaphragmatic hernia herniation. The association of CDH with meg- with the stomach and intestines located in the left aesophagus has been described earlier and hemithorax (Figure 1).
    [Show full text]
  • Pediatric Gastroesophageal Reflux Clinical Practice
    SOCIETY PAPER Pediatric Gastroesophageal Reflux Clinical Practice Guidelines: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition ÃRachel Rosen, yYvan Vandenplas, zMaartje Singendonk, §Michael Cabana, jjCarlo DiLorenzo, ôFrederic Gottrand, #Sandeep Gupta, ÃÃMiranda Langendam, yyAnnamaria Staiano, zzNikhil Thapar, §§Neelesh Tipnis, and zMerit Tabbers ABSTRACT This document serves as an update of the North American Society for Pediatric INTRODUCTION Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European n 2009, the joint committee of the North American Society for Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Pediatric Gastroenterology, Hepatology, and Nutrition (NASP- 2009 clinical guidelines for the diagnosis and management of gastroesophageal GHAN)I and the European Society for Pediatric Gastroenterology, refluxdisease(GERD)ininfantsandchildrenandisintendedtobeappliedin Hepatology, and Nutrition (ESPGHAN) published a medical posi- daily practice and as a basis for clinical trials. Eight clinical questions addressing tion paper on gastroesophageal reflux (GER) and GER disease diagnostic, therapeutic and prognostic topics were formulated. A systematic (GERD) in infants and children (search until 2008), using the 2001 literature search was performed from October 1, 2008 (if the question was NASPGHAN guidelines as an outline (1). Recommendations were addressed
    [Show full text]
  • Abdominal Wall Defects—Current Treatments
    children Review Abdominal Wall Defects—Current Treatments Isabella N. Bielicki 1, Stig Somme 2, Giovanni Frongia 3, Stefan G. Holland-Cunz 1 and Raphael N. Vuille-dit-Bille 1,* 1 Department of Pediatric Surgery, University Children’s Hospital of Basel (UKBB), 4056 Basel, Switzerland; [email protected] (I.N.B.); [email protected] (S.G.H.-C.) 2 Department of Pediatric Surgery, University Children’s Hospital of Colorado, Aurora, CO 80045, USA; [email protected] 3 Section of Pediatric Surgery, Department of General, Visceral and Transplantation Surgery, 69120 Heidelberg, Germany; [email protected] * Correspondence: [email protected]; Tel.: +41-61-704-27-98 Abstract: Gastroschisis and omphalocele reflect the two most common abdominal wall defects in newborns. First postnatal care consists of defect coverage, avoidance of fluid and heat loss, fluid administration and gastric decompression. Definitive treatment is achieved by defect reduction and abdominal wall closure. Different techniques and timings are used depending on type and size of defect, the abdominal domain and comorbidities of the child. The present review aims to provide an overview of current treatments. Keywords: abdominal wall defect; gastroschisis; omphalocele; treatment 1. Gastroschisis Citation: Bielicki, I.N.; Somme, S.; 1.1. Introduction Frongia, G.; Holland-Cunz, S.G.; Gastroschisis is one of the most common congenital abdominal wall defects in new- Vuille-dit-Bille, R.N. Abdominal Wall borns. Children born with gastroschisis have a full-thickness paraumbilical abdominal Defects—Current Treatments. wall defect, which is associated with evisceration of bowel and sometimes other organs Children 2021, 8, 170.
    [Show full text]
  • Albany Med Conditions and Treatments
    Albany Med Conditions Revised 3/28/2018 and Treatments - Pediatric Pediatric Allergy and Immunology Conditions Treated Services Offered Visit Web Page Allergic rhinitis Allergen immunotherapy Anaphylaxis Bee sting testing Asthma Drug allergy testing Bee/venom sensitivity Drug desensitization Chronic sinusitis Environmental allergen skin testing Contact dermatitis Exhaled nitric oxide measurement Drug allergies Food skin testing Eczema Immunoglobulin therapy management Eosinophilic esophagitis Latex skin testing Food allergies Local anesthetic skin testing Non-HIV immune deficiency disorders Nasal endoscopy Urticaria/angioedema Newborn immune screening evaluation Oral food and drug challenges Other specialty drug testing Patch testing Penicillin skin testing Pulmonary function testing Pediatric Bariatric Surgery Conditions Treated Services Offered Visit Web Page Diabetes Gastric restrictive procedures Heart disease risk Laparoscopic surgery Hypertension Malabsorptive procedures Restrictions in physical activities, such as walking Open surgery Sleep apnea Pre-assesment Pediatric Cardiothoracic Surgery Conditions Treated Services Offered Visit Web Page Aortic valve stenosis Atrial septal defect repair Atrial septal defect (ASD Cardiac catheterization Cardiomyopathies Coarctation of the aorta repair Coarctation of the aorta Congenital heart surgery Congenital obstructed vessels and valves Fetal echocardiography Fetal dysrhythmias Hypoplastic left heart repair Patent ductus arteriosus Patent ductus arteriosus ligation Pulmonary artery stenosis
    [Show full text]
  • Tongue-Ties and Sleep Issues (And More!) by Richard Baxter, DMD, MS, DABLS
    LASERfocus Tongue-Ties and Sleep Issues (and More!) by Richard Baxter, DMD, MS, DABLS tongue-tie is a thick, tight, or short string of tissue under the tongue that restricts the tongue’s movement and causes a A functional issue. Collectively, tongue-ties and lip-ties are referred to as tethered oral tissues. They are often misdiagnosed or misunderstood, and they are quite common. The frequency with which anterior tongue-ties occur is estimated to range from 4-10% in the general population, and posterior tongue-ties have been reported in as many as 32.5% of infants in a recent study.1 flat palate, the baby is born with a high arched For a tight piece of tissue to qualify as a tongue-tie, it must have or “bubble” palate which leaves less room for a functional impact on nursing, speech, feeding, or sleep. Infant the base of the nose and less volume available problems arising from tongue-ties include painful and prolonged for the nasal cavity. Tongue-ties also lead to several of the main causes of breastfeeding nursing episodes, poor stimulation of maternal milk production, cessation, including nipple pain, trouble reflux, slow weight gain, gassiness, and a host of other issues for latching, and concerns that the baby is not mom and/or baby. As babies advance to eating solids, tongue- getting enough milk.3 It has been demon- strated in many controlled studies that releas- ties can lead to gagging, refusing food, spitting out food, and ing tongue-ties, whether classic near-the-tip picky eating.
    [Show full text]
  • Bruce R. Maddern M.D., P.A. Post Frenuloplasty (Procedure to Resolve
    Bruce R. Maddern M.D., P.A. Post Frenuloplasty (procedure to resolve “tongue-tie”) Instructions Ankyloglossia (“tongue-tie”) is a condition present from birth in which movement of the tongue tip is restricted due to an unusually short and/or thick frenulum. A frenulum is a band of tissue that anchors the tongue to the floor of the mouth behind the teeth. When the frenulum is too short or tight, the tongue tip is unable to move freely. This may result in difficulty with early bottle or breast-feeding or future speech articulation. The most common reason to perform frenuloplasty in a newborn is difficulty with feeding or latching. It is often possible to perform the procedure in office for infants under 6 months of age with a local anesthetic. The baby can feed immediately following the procedure. In toddlers it may be necessary to perform a frenuloplasty because of speech articulation issues. If a frenuloplasty is required for this age group the procedure occurs in the operating room under a brief general anesthesia. The entire procedure usually is complete with in 15 minutes. Speech therapy is necessary to ensure improved mobility of the tongue for older children. General risks from frenuloplasty include bleeding, pain, scarring, and infection. General Information • The patient may resume normal activity following surgery, including normal feeding schedule (bottle, breast, or soft food). • The patient may return to daycare the next day. • Some discomfort or tongue swelling is expected following this procedure. You may treat your child with Tylenol or Ibuprofen. • For infants the normal movements of the tongue during breast of bottle feeding is adequate stretching • Ice pops are a good way to numb the area.
    [Show full text]
  • Treatments for Ankyloglossia and Ankyloglossia with Concomitant Lip-Tie Comparative Effectiveness Review Number 149
    Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Comparative Effectiveness Review Number 149 Treatments for Ankyloglossia and Ankyloglossia With Concomitant Lip-Tie Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract No. 290-2012-00009-I Prepared by: Vanderbilt Evidence-based Practice Center Nashville, TN Investigators: David O. Francis, M.D., M.S. Sivakumar Chinnadurai, M.D., M.P.H. Anna Morad, M.D. Richard A. Epstein, Ph.D., M.P.H. Sahar Kohanim, M.D. Shanthi Krishnaswami, M.B.B.S., M.P.H. Nila A. Sathe, M.A., M.L.I.S. Melissa L. McPheeters, Ph.D., M.P.H. AHRQ Publication No. 15-EHC011-EF May 2015 This report is based on research conducted by the Vanderbilt Evidence-based Practice Center (EPC) under contract to the Agency for Healthcare Research and Quality (AHRQ), Rockville, MD (Contract No. 290-2012-00009-I). The findings and conclusions in this document are those of the authors, who are responsible for its contents; the findings and conclusions do not necessarily represent the views of AHRQ. Therefore, no statement in this report should be construed as an official position of AHRQ or of the U.S. Department of Health and Human Services. The information in this report is intended to help health care decisionmakers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services. This report is not intended to be a substitute for the application of clinical judgment.
    [Show full text]
  • Guideline for the Evaluation of Cholestatic Jaundice
    CLINICAL GUIDELINES Guideline for the Evaluation of Cholestatic Jaundice in Infants: Joint Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition ÃRima Fawaz, yUlrich Baumann, zUdeme Ekong, §Bjo¨rn Fischler, jjNedim Hadzic, ôCara L. Mack, #Vale´rie A. McLin, ÃÃJean P. Molleston, yyEzequiel Neimark, zzVicky L. Ng, and §§Saul J. Karpen ABSTRACT Cholestatic jaundice in infancy affects approximately 1 in every 2500 term PREAMBLE infants and is infrequently recognized by primary providers in the setting of holestatic jaundice in infancy is an uncommon but poten- physiologic jaundice. Cholestatic jaundice is always pathologic and indicates tially serious problem that indicates hepatobiliary dysfunc- hepatobiliary dysfunction. Early detection by the primary care physician and tion.C Early detection of cholestatic jaundice by the primary care timely referrals to the pediatric gastroenterologist/hepatologist are important physician and timely, accurate diagnosis by the pediatric gastro- contributors to optimal treatment and prognosis. The most common causes of enterologist are important for successful treatment and an optimal cholestatic jaundice in the first months of life are biliary atresia (25%–40%) prognosis. The Cholestasis Guideline Committee consisted of 11 followed by an expanding list of monogenic disorders (25%), along with many members of 2 professional societies: the North American Society unknown or multifactorial (eg, parenteral nutrition-related) causes, each of for Gastroenterology, Hepatology and Nutrition, and the European which may have time-sensitive and distinct treatment plans. Thus, these Society for Gastroenterology, Hepatology and Nutrition. This guidelines can have an essential role for the evaluation of neonatal cholestasis committee has responded to a need in pediatrics and developed to optimize care.
    [Show full text]
  • Ankyloglossia and Oral Frena Consensus Statement
    Acknowledgments The Australian Dental Association, in association with an expert multidisciplinary panel of health professionals has developed the Ankyloglossia and Oral Frena Consensus Statement to provide evidence-based recommendations to guide best practice in caring for individuals with short, tight labial and lingual frena and ankyloglossia. Working group members are acknowledged below. Expert working group members Chair Dr Mihiri Silva (Paediatric Dentist) BDSc, MDSc, DCD (Paediatric Dentistry), PhD Australasian Academy of Paediatric Dentistry Dr Kareen Mekertichian (Paediatric Dentist) (AAPD) BDS, MDSc, FRACDS, MRACDS (Paed Dent), FICD, FPFA Australian Chiropractors Association (ACA) Dr Russell Mottram (Chiropractor) B.App.Sc (Chiropractic) Australian College of Midwives (ACM) Ms Lois Wattis (Clinical Midwife and IBCLC) BNurs, PGradDipMidwifery, FACM, IBCLC Australian College of Midwives (ACM) Ms Michelle Simmons (Clinical Midwife Consultant, Westmead) MNurs, IBCLC Australian Dental Association (ADA) Prof Laurence Walsh (Specialist in Special Needs Dentistry) BDSc, PhD, DDSc, GCEd, FRACDS, FFOP (RCPA) Australian Dental Association (ADA) Dr Philippa Sawyer (Paediatric Dentist) BDS (USyd), MA (Sports Studies) (UTS), GradCertPedDent (NYU) PGCertHEd (MQU), Master of Early Childhood (MQU), FICD, FAAPD, FIADT Diplomate, American Board of Pediatric Dentistry Australian Dental Association (ADA) Ms Eithne Irving Deputy CEO & Policy General Manager RN, Grad Dip Neuroscience, MBA Australian Dental Association (ADA) Dr Mikaela Chinotti (Dentist) Oral Health Promoter BDS, MPH Australian Dental & Oral Health Therapists' Ms Nicole Stormon (Oral Health Therapist) Association (ADOHTA) BOH, AFHEA Australian and New Zealand Association of Oral and A/Prof David Sherring (Oral and Maxillofacial Surgeon) Maxillofacial Surgeons (ANZAOMS) MBBS, BDS, DClinDent, FRACDS (OMS) President ANZAOMS (2017-2019) Lactation Consultants of Australia & New Zealand Ms Heather Gale (IBCLC, Registered Nurse and Midwife) (LCANZ) IBCLC/RN/RM/Post grad.
    [Show full text]
  • Intestinal Malrotation: a Diagnosis to Consider in Acute Abdomen In
    Submitted on: 05/20/2018 Approved on: 08/07/2018 CASE REPORT Intestinal malrotation: a diagnosis to consider in acute abdomen in newborns Antônio Augusto de Andrade Cunha Filho1, Paula Aragão Coimbra2, Adriana Cartafina Perez-Bóscollo3, Robson Azevedo Dutra4, Katariny Parreira de Oliveira Alves5 Keywords: Abstract Intestinal obstruction, Intestinal malrotation is an anomaly of the midgut, resulting from an embryonic defect during the phases of herniation, Acute abdomen, rotation, and fixation. The objective is to report a case of complex diagnostics and approach. The diagnosis was made Gastrointestinal tract. surgically in a patient presenting with hemodynamic instability, abdominal distension, signs of intestinal obstruction, and pneumoperitoneum on abdominal X-ray, with suspected grade III necrotizing enterocolitis. During surgery, a volvulus resulting from poor intestinal rotation was found at a distance of 12 cm from the ileocecal valve. Hemodynamic instability and abdominal distension recurred, and another exploratory laparotomy was required to correct new intestinal perforations. Therefore, early diagnosis with surgical correction before a volvulus appears is essential. Abdominal Doppler ultrasonography has been promising for early diagnosis. 1 Academic in Medicine - Federal University of the Triângulo Mineiro - Uberaba - Minas Gerais - Brazil 2 Resident in Pediatric Intensive Care - Federal University of the Triângulo Mineiro - Uberaba - Minas Gerais - Brazil 3 Associate Professor - Federal University of the Triângulo Mineiro - Uberaba - Minas Gerais - Brazil. 4 Adjunct Professor - Federal University of the Triângulo Mineiro - Uberaba - Minas Gerais - Brazil 5 Academic in Medicine - Federal University of the Triângulo Mineiro - Uberaba - Minas Gerais - Brazil Correspondence to: Antônio Augusto de Andrade Cunha Filho. Universidade Federal do Triângulo Mineiro, Acadêmico de Medicina - Uberaba - Minas Gerais - Brasil.
    [Show full text]